Clinical pharmacists’ intervention on pain management in cancer patients (PharmaCAP trial): study protocol for a randomized controlled trial

References

• Merskey HE. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Pain 1986.
   Google Scholar
• van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJUpdate on prevalence of pain in patients with cancer: systematic review and meta-analysisJ Pain Symptom Manage201651610701090.e1079 https://doi.org/10.1016/j.jpainsymman.2015.12.340
   PubMed Web of Science ®Google Scholar
• Kroenke K, Theobald D, Wu J, Loza JK, Carpenter JS, Tu WThe association of depression and pain with health-related quality of life, disability, and health care use in cancer patientsJ Pain Symptom Manage2010403327341 https://doi.org/10.1016/j.jpainsymman.2009.12.023
   PubMed Web of Science ®Google Scholar
• Rustøen T, Moum T, Padilla G, Paul S, Miaskowski CPredictors of quality of life in oncology outpatients with pain from bone metastasisJ Pain Symptom Manage2005303234242 https://doi.org/10.1016/j.jpainsymman.2005.04.002
   PubMed Web of Science ®Google Scholar
• Green CR, Hart-Johnson T, Loeffler DRCancer-related chronic pain: examining quality of life in diverse cancer survivorsCancer2011117919942003 https://doi.org/10.1002/cncr.25761
   PubMed Web of Science ®Google Scholar
• Fortner BV, Demarco G, Irving G, Ashley J, Keppler G, Chavez J, Munk JDescription and predictors of direct and indirect costs of pain reported by cancer patientsJ Pain Symptom Manage2003251918 https://doi.org/10.1016/S0885-3924(02)00597-3
   PubMed Web of Science ®Google Scholar
• O'Mahony S, Goulet JL, Payne RPsychosocial distress in patients treated for cancer pain: a prospective observational studyJ Opioid Manag201063211222 https://doi.org/10.5055/jom.2010.0019
   PubMedGoogle Scholar
• Laird BJ, Boyd AC, Colvin LA, Fallon MTAre cancer pain and depression interdependent? A systematic reviewPsychooncology2009185459464 https://doi.org/10.1002/pon.1431
   PubMed Web of Science ®Google Scholar
• Zhang L, McLeod HL, Liu KK, Liu WH, Huang HX, Huang YM, Sun SS, Chen XP, Chen Y, Liu FZ, et al.Effect of physician–pharmacist participation in the management of ambulatory cancer pain through a digital health platform: randomized controlled trialJMIR Mhealth Uhealth202198 https://doi.org/10.2196/24555
   Web of Science ®Google Scholar
• Wang Y, Huang H, Zeng Y, Wu J, Wang R, Ren B, Xu FPharmacist-led medication education in cancer pain control: a multicentre randomized controlled study in Guangzhou, ChinaJ Int Med Res201341514621472 https://doi.org/10.1177/0300060513491170
   PubMed Web of Science ®Google Scholar
• Liu J, Wang C, Chen X, Luo J, Xie J, Li S, Hu J, Shi CEvaluation of pharmacist interventions as part of a multidisciplinary cancer pain management team in a Chinese academic medical centerJ Am Pharm Assoc (2003)20206017680 https://doi.org/10.1016/j.japh.2019.09.005
   PubMed Web of Science ®Google Scholar
• Shrestha S, Kc B, Blebil AQ, Teoh SLPharmacist involvement in cancer pain management: a systematic review and meta-analysisJ Pain.202223711231142 1:CAS:528:DC%2BB38Xht1Kmtr7L https://doi.org/10.1016/j.jpain.2022.02.002
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fuchs HE, Jemal ACancer statistics, 2022CA Cancer J Clin2022721733 https://doi.org/10.3322/caac.21708
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray FGlobal Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCA Cancer J Clin2021713209249 https://doi.org/10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Wang B, He F, Hu Y, Wang Q, Wang D, Sha Y, Wu JCancer incidence and mortality and risk factors in member countries of the " Belt and Road " initiativeBMC Cancer2022221582 https://doi.org/10.1186/s12885-022-09657-3
   PubMed Web of Science ®Google Scholar
• Kocarnik JM, Compton K, Dean FE, Fu W, Gaw BL, Harvey JD, Henrikson HJ, Lu D, Pennini A, Xu RCancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the Global Burden of Disease Study 2019JAMA Oncol202283420444 https://doi.org/10.1001/jamaoncol.2021.6987
   PubMed Web of Science ®Google Scholar
• Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, Pletcher MA, Smith AE, Tang K, Yuan C-WForecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territoriesLancet20183921015920522090 https://doi.org/10.1016/S0140-6736(18)31694-5
   PubMed Web of Science ®Google Scholar
• World cancer report: cancer research for cancer prevention. Available from: https://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports/World-Cancer-Report-Cancer-Research-For-Cancer-Prevention-2020. Accessed 17 Apr 2022.
   Google Scholar
• Shrestha G, Thakur RK, Singh R, Mulmi R, Shrestha A, Pradhan PMSCancer burden in Nepal, 1990–2017: an analysis of the Global Burden of Disease studyPLoS ONE2021168 1:CAS:528:DC%2BB3MXhslKrtrvO https://doi.org/10.1371/journal.pone.0255499
   Web of Science ®Google Scholar
• Mishra SR, Neupane D, Bhandari PM, Khanal V, Kallestrup PBurgeoning burden of non-communicable diseases in Nepal: a scoping reviewGlob Health20151132 https://doi.org/10.1186/s12992-015-0119-7
   PubMed Web of Science ®Google Scholar
• Nepal Factsheet [Internet] Geneva: World Health Organization. Available from: https://gco.iarc.fr/today/data/factsheets/populations/524-nepal-fact-sheets.pdf. Accessed 16 Apr2022.
   Google Scholar
• Shrestha S, Shakya D, Palaian SClinical pharmacy education and practice in Nepal: a glimpse into present challenges and potential solutionsAdv Med Educ Pract202011541548 https://doi.org/10.2147/AMEP.S257351
   PubMed Web of Science ®Google Scholar
• Shrestha S, Shrestha S, Sapkota B, Shakya R, Roien R, Mohamed Ibrahim MIReintroduction of post-baccalaureate doctor of pharmacy (PharmD, Post-Bac) program in Nepal: exploration of the obstacles and solutions to move forwardAdv Med Educ Pract202213159166 https://doi.org/10.2147/AMEP.S348601
   PubMed Web of Science ®Google Scholar
• Eldridge SM, Lancaster GA, Campbell MJ, Thabane L, Hopewell S, Coleman CL, Bond CMDefining feasibility and pilot studies in preparation for randomised controlled trials: development of a conceptual frameworkPLoS ONE2016113 https://doi.org/10.1371/journal.pone.0150205
   Web of Science ®Google Scholar
• O’Cathain A, Hoddinott P, Lewin S, Thomas KJ, Young B, Adamson J, Jansen YJFM, Mills N, Moore G, Donovan JLMaximising the impact of qualitative research in feasibility studies for randomised controlled trials: guidance for researchersPilot Feasibil Stud20151132 https://doi.org/10.1186/s40814-015-0026-y
   PubMedGoogle Scholar
• Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, Hróbjartsson A, Mann H, Dickersin K, Berlin JA, et al.SPIRIT 2013 statement: defining standard protocol items for clinical trialsAnn Intern Med20131583200207 https://doi.org/10.7326/0003-4819-158-3-201302050-00583
   PubMed Web of Science ®Google Scholar
• Chan AW, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, Dickersin K, Hróbjartsson A, Schulz KF, Parulekar WR, et al.SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trialsBMJ2013346 https://doi.org/10.1136/bmj.e7586
   Google Scholar
• Billingham SA, Whitehead AL, Julious SAAn audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom Clinical Research Network databaseBMC Med Res Methodol201313116 https://doi.org/10.1186/1471-2288-13-104
   PubMedGoogle Scholar
• Althubaiti AInformation bias in health research: definition, pitfalls, and adjustment methodsJ Multidiscip Healthc20169211217 https://doi.org/10.2147/JMDH.S104807
   PubMed Web of Science ®Google Scholar
• Cleeland C, Ryan K. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap 1994.
   Google Scholar
• Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, Pandya KJPain and its treatment in outpatients with metastatic cancerN Engl J Med19943309592596 1:STN:280:DyaK2c7jsVWnsw%3D%3D https://doi.org/10.1056/NEJM199403033300902
   PubMed Web of Science ®Google Scholar
• Cleeland CSThe brief pain inventory user guide2009Houston, TXThe University of Texas MD Anderson Cancer Center111
   Google Scholar
• Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan KThe Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patientsJ Palliat Care19917269 1:STN:280:DyaK3Mzjt1OqtA%3D%3D https://doi.org/10.1177/082585979100700202
   PubMedGoogle Scholar
• Watanabe SM, Nekolaichuk C, Beaumont C, Johnson L, Myers J, Strasser FA multicenter study comparing two numerical versions of the Edmonton Symptom Assessment System in palliative care patientsJ Pain Symptom Manage2011412456468 https://doi.org/10.1016/j.jpainsymman.2010.04.020
   PubMed Web of Science ®Google Scholar
• Chan AHY, Horne R, Hankins M, Chisari CThe medication adherence report scale: a measurement tool for eliciting patients' reports of nonadherenceBr J Clin Pharmacol202086712811288 https://doi.org/10.1111/bcp.14193
   PubMed Web of Science ®Google Scholar
• Risal A, Manandhar K, Linde M, Koju R, Steiner TJ, Holen AReliability and validity of a Nepali-language Version of the Hospital Anxiety and Depression Scale (HADS)Kathmandu Univ Med J (KUMJ)20151350115124 1:STN:280:DC%2BC28rhsF2ktA%3D%3D
   PubMedGoogle Scholar
• Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al.The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncologyJ Natl Cancer Inst1993855365376 1:STN:280:DyaK3s7msVarsQ%3D%3D https://doi.org/10.1093/jnci/85.5.365
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. Available from: https://evs.nci.nih.gov/ftp1/CTCAE/. Accessed 18 Apr 2022.
   Google Scholar
• Shanyinde M, Pickering RM, Weatherall MQuestions asked and answered in pilot and feasibility randomized controlled trialsBMC Med Res Methodol201111117 https://doi.org/10.1186/1471-2288-11-117
   PubMed Web of Science ®Google Scholar